Oncology & Cancer

No link found for metformin or statins and ovarian cancer

(HealthDay)—In women with type 2 diabetes, no evidence was found of an association between the use of metformin or statins and the incidence of ovarian cancer, according to a study published online Feb. 7 in BJOG: An International ...

Diabetes

Metformin after induction Tx may preserve beta-cell function

(HealthDay)—After induction short-term intensive insulin therapy (IIT), metformin is superior to intermittent IIT for maintaining beta-cell function and glycemic control over two years, according to a study published online ...

Diabetes

First-line metformin use for DM up; sulfonylurea use down

(HealthDay)—Among patients with type 2 diabetes initiating antidiabetes drugs (ADDs), first-line use of metformin has increased since 2005, while sulfonylureas have remained the most popular second-line agent, according ...

Diabetes

Clinical evidence synopsis published for T2DM

(HealthDay)—Adding a sulfonylurea or metformin to insulin is associated with approximately a 1 percent reduction in hemoglobin A1c (HbA1c), and addition of a sulfonylurea (but not metformin) is associated with more hypoglycemic ...

Diabetes

Lifestyle, metformin interventions have variable effects

(HealthDay)—For individuals with impaired glucose regulation, the impact of lifestyle and metformin interventions vary for progression to diabetes mellitus (DM) and likelihood of regression to normal glucose regulation ...

Diabetes

Venovenous hemodiafiltration improves metformin toxicity

(HealthDay)—High-volume continuous venovenous hemodiafiltration (CVVH) and resin-sorbent hemoperfusion is effective for eliminating metformin, according to a case study published online Oct. 5 in the Journal of Diabetes ...

page 14 from 32